239 related articles for article (PubMed ID: 25350484)
21. Etiology and management of pyoderma gangrenosum: a comprehensive review.
Ahronowitz I; Harp J; Shinkai K
Am J Clin Dermatol; 2012 Jun; 13(3):191-211. PubMed ID: 22356259
[TBL] [Abstract][Full Text] [Related]
22. Neutrophilic dermatoses: a review of current treatment options.
Cohen PR
Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
[TBL] [Abstract][Full Text] [Related]
23. What do autoinflammatory syndromes teach about common cutaneous diseases such as pyoderma gangrenosum? A commentary.
Butler D; Shinkai K
Dermatol Clin; 2013 Jul; 31(3):427-35. PubMed ID: 23827245
[TBL] [Abstract][Full Text] [Related]
24. A sporadic case of pyogenic arthritis, pyoderma gangrenosum and acne syndrome without an identifiable mutation.
Park BM; Yun SJ; Lee SC; Lee JB
Clin Exp Dermatol; 2014 Jan; 39(1):73-5. PubMed ID: 23692517
[No Abstract] [Full Text] [Related]
25. Pyogenic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa (PAPASH): a new autoinflammatory syndrome associated with a novel mutation of the PSTPIP1 gene.
Marzano AV; Trevisan V; Gattorno M; Ceccherini I; De Simone C; Crosti C
JAMA Dermatol; 2013 Jun; 149(6):762-4. PubMed ID: 23571383
[No Abstract] [Full Text] [Related]
26. Pyoderma gangrenosum, acne and suppurative hidradenitis syndrome following bowel bypass surgery.
Marzano AV; Ishak RS; Colombo A; Caroli F; Crosti C
Dermatology; 2012; 225(3):215-9. PubMed ID: 23171584
[TBL] [Abstract][Full Text] [Related]
27. Mutations in the PSTPIP1 gene and aberrant splicing variants in patients with pyoderma gangrenosum.
Nesterovitch AB; Hoffman MD; Simon M; Petukhov PA; Tharp MD; Glant TT
Clin Exp Dermatol; 2011 Dec; 36(8):889-95. PubMed ID: 21790734
[TBL] [Abstract][Full Text] [Related]
28. Pediatric Pyoderma Gangrenosum: A Retrospective Review of Clinical Features, Etiologic Associations, and Treatment.
Schoch JJ; Tolkachjov SN; Cappel JA; Gibson LE; Davis DM
Pediatr Dermatol; 2017 Jan; 34(1):39-45. PubMed ID: 27699861
[TBL] [Abstract][Full Text] [Related]
29. Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis.
Scheinfeld N
Dermatol Online J; 2013 Jun; 19(6):18558. PubMed ID: 24011308
[TBL] [Abstract][Full Text] [Related]
30. Pyoderma gangrenosum-like lesion secondary to methylenetetrahydrofolate reductase mutation: an unusual presentation of a rare disease.
Turkowski Y; Razvi S; Ahmed AR
BMJ Case Rep; 2019 Apr; 12(4):. PubMed ID: 31015243
[TBL] [Abstract][Full Text] [Related]
31. First nicastrin mutation in PASH (pyoderma gangrenosum, acne and suppurative hidradenitis) syndrome.
Duchatelet S; Miskinyte S; Join-Lambert O; Ungeheuer MN; Francès C; Nassif A; Hovnanian A
Br J Dermatol; 2015 Aug; 173(2):610-2. PubMed ID: 25601011
[No Abstract] [Full Text] [Related]
32. [Multilocular pyoderma gangrenosum : Association with primary manifestation of primary biliary cholangitis].
Kögel J; Berneburg M; Karrer S; Drexler K; Niebel D
Dermatologie (Heidelb); 2023 Jul; 74(7):538-542. PubMed ID: 37326669
[TBL] [Abstract][Full Text] [Related]
33. Pyoderma gangrenosum after orthopaedic or traumatologic surgery: a systematic revue of the literature.
Ebrad S; Severyns M; Benzakour A; Roze B; Derancourt C; Odri GA; Rouvillain JL
Int Orthop; 2018 Feb; 42(2):239-245. PubMed ID: 29119297
[TBL] [Abstract][Full Text] [Related]
34. Pyoderma gangrenosum in hematologic malignancies: A systematic review.
Montagnon CM; Fracica EA; Patel AA; Camilleri MJ; Murad MH; Dingli D; Wetter DA; Tolkachjov SN
J Am Acad Dermatol; 2020 Jun; 82(6):1346-1359. PubMed ID: 31560977
[TBL] [Abstract][Full Text] [Related]
35. Haematological involvement associated with a mild autoinflammatory phenotype, in two patients carrying the E250K mutation of PSTPIP1.
Belelli E; Passarelli C; Pardeo M; Holzinger D; De Benedetti F; Insalaco A
Clin Exp Rheumatol; 2017; 35 Suppl 108(6):113-115. PubMed ID: 28628471
[TBL] [Abstract][Full Text] [Related]
36. Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra.
Brenner M; Ruzicka T; Plewig G; Thomas P; Herzer P
Br J Dermatol; 2009 Nov; 161(5):1199-201. PubMed ID: 19673875
[TBL] [Abstract][Full Text] [Related]
37. Peculiarities of PAPA syndrome.
Tallon B; Corkill M
Rheumatology (Oxford); 2006 Sep; 45(9):1140-3. PubMed ID: 16527883
[TBL] [Abstract][Full Text] [Related]
38. Drug-induced pyoderma gangrenosum: a model to understand the pathogenesis of pyoderma gangrenosum.
Wu BC; Patel ED; Ortega-Loayza AG
Br J Dermatol; 2017 Jul; 177(1):72-83. PubMed ID: 27864925
[TBL] [Abstract][Full Text] [Related]
39. Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome) with E250K mutation in CD2BP1 gene treated with the tumor necrosis factor inhibitor adalimumab.
Lee H; Park SH; Kim SK; Choe JY; Park JS
Clin Exp Rheumatol; 2012; 30(3):452. PubMed ID: 22513199
[No Abstract] [Full Text] [Related]
40. [Extensive ulcerations in children: The difficulty diagnosing pyoderma gangrenosum].
Ramli I; Rachadi H; Amarouch H; Rimani M; Senouci K; Benzekri L; Hassam B
Arch Pediatr; 2015 Jul; 22(7):753-5. PubMed ID: 26047747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
